JMJubert Marquez

Jubert Marquez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jubert Marquez has a total of 63 co-authors. Here are the top co-authors by number of shared publications:

  • Jin Han

    Basic Research Laboratory, Department of Physiology, College of Medicine, Smart Marine Therapeutic Center, Cardiovascular and Metabolic Disease Core Research Support Center, Inje University, Busan, Korea

    6 shared publications
  • Joseph Rey H. Sta. Agueda

    Department of Manufacturing Engineering and Management, De La Salle University, Manila 1004, Philippines

    3 shared publications
  • Nammi Park

    Basic Research Laboratory, Department of Physiology, College of Medicine, Smart Marine Therapeutic Center, Cardiovascular and Metabolic Disease Core Research Center, Inje University, Busan 47392, Korea

    3 shared publications
  • Hyoung Kyu Kim

    Basic Research Laboratory, Department of Physiology, College of Medicine, Smart Marine Therapeutic Center, Cardiovascular and Metabolic Disease Core Research Center, Inje University, Busan 47392, Korea

    2 shared publications
  • Hyoung Kyu Kim

    Basic Research Laboratory, Department of Physiology, College of Medicine, Smart Marine Therapeutic Center, Cardiovascular and Metabolic Disease Core Research Support Center, Inje University, Busan, Korea

    2 shared publications
  • Jessa Flores

    Basic Research Laboratory, Department of Physiology, College of Medicine, Smart Marine Therapeutic Center, Cardiovascular and Metabolic Disease Core Research Center, Inje University, Busan 47392, Korea

    2 shared publications

Latest Publications

  • Bio-alchemy: a review of bacterial mechanisms for heavy metal sequestration, transformation, and bioremediation

    by Michael Josh Ramirez, Iza Clare Mira, Dyanne Jasmine Rafael, Vincent Chuabio, Bernadette Bagon, Jubert Marquez

  • Open Access

    Fabrication, Simulation, and Mechanical Characterization of Curcumin-Loaded PVA/PVP Microneedle Arrays Using Custom 3D-Printed Molds

    by Bryan Angelo S. J. Basa, Charlize Dawn Z. Batin, Izabelle Nisha Maxine D. Chan, Adrian Ray B. Gabay, John Ray C. Estrellado, Ron Gilbert R. Rallos, Mary Stephanie S. Carranza, Mark Jefferson U. Lim, Jubert C. Marquez, Joseph Rey H. Sta Agueda

    Microneedle (MN) arrays offer a novel and minimally invasive platform for transdermal drug delivery. This study presents an approach for the design and fabrication of MN array models for biomedical applications using custom 3D-printed micro-molds. Material analysis of the polyvinyl alcohol (PVA) and polyvinylpyrrolidone (PVP) matrix in a 3:1 weight ratio was conducted under varying geometric configurations, curcumin (CUR) dosages, and target penetration depths of 300 to 500 μm. Computational simulation using computer-aided design (CAD) and finite element analysis (FEA) on ANSYS (Canonsburg, PN, USA) measured for total deformation, stress distribution, insertion pressure, and factor of safety. Elimination criteria were applied, narrowing down to specific models that were experimentally validated through material formulation, micro-molding, and material characterization. The selected MN models were analyzed by insertion and penetration efficiency testing on porcine skin. The results showed that higher CUR concentrations reduced mechanical strength and Young’s modulus, while mid-range dosages (2–6 mg) combined with optimized geometric spacing produced MNs with maintained structural integrity and effective performance. Conical microneedles demonstrated the most favorable balance of mechanical stability, controlled swelling behavior, and high insertion efficiency. The study recommends this approach as a feasible and reproducible method for localized wound-healing applications.


  • Open Access

    Healing the Sole: Combining Natural Plant Extracts and Conventional Drugs in Wound Delivery Systems for Diabetic Foot Ulcer Treatment

    by Raneille Quirsten Baligod, Izliah Grace Nicole Fabian, Kristine Margreth Repol, Heidi Lindt Sy, Jubert Marquez, Joseph Rey Sta. Agueda

    Diabetic foot ulcers (DFUs) affect 19–34% of diabetic patients with a five-year mortality rate of 50–70%. It is characterized by a high infection risk, chronic inflammation, oxidative stress, and poor angiogenesis, rendering existing therapies inadequate, which causes antimicrobial resistance and amputations. Bioactive compounds, such as curcumin, flavonoids, tannins, polyphenols, and proteins, found in natural product extracts (NPEs) have antibacterial, anti-inflammatory, antioxidant, and regenerative properties but are prone to variability and instability. Conventional drugs can be applied for targeted infection management and metabolic modulation, but lack regenerative capacity. The combined and synergistic potential of these two agents has not received much attention, especially when integrated into advanced drug delivery systems (DDSs), such as microneedles, hydrogels, nanofibers, and smart bandages. This review discusses NPEs, conventional drugs, combinations, and integration into DDSs, based on wound characteristics. These include depth, infection status, exudate level, and perfusion, as recommended by the 2023 IWGDF guidelines. Three combinations have shown promise in preclinical studies: propolis-charcoal bandages, propolis-oregano microneedles, and Centella-ZnO nanocomposites. However, none have yet been validated in clinical settings, and barriers to clinical adoption persist—standardization, stability, and regulatory issues. This work aims to pave the way for more accessible, sustainable, and efficacious DFU therapeutics by bridging natural and conventional approaches.

  • Open Access

    Mitochondrial reprogramming as a central driver of pancreatic ductal adenocarcinoma

    by Jed Allyn T. Hernandez, Prycelline M. Abedejos, Kianna Denise F. Lopez, Alessandra Beatrice L. Donado, Mariel Denise A. Roque, Kirsten Ysabelle V. Serranilla, Ju Eun Seol, Jessa E. Flores, Maria Victoria Faith V. Garcia, Jubert C. Marquez, et al.

  • Open Access

    Cereblon upregulation overcomes thalidomide resistance in multiple myeloma through mitochondrial functional reprogramming

    by Jubert Marquez, Nammi Park, Jae Hyeog Choi, Maria Victoria Faith Garcia, Jessa Flores, Bayalagmaa Nyamaa, Jung Eun Seol, Hyoung Kyu Kim, Myung Geun Shin, Sae Gwang Park, et al.

    Jubert Marquez, Nammi Park, Jae Hyeog Choi, Maria Victoria Faith Garcia, Jessa Flores, Bayalagmaa Nyamaa, Jung Eun Seol, Hyoung Kyu Kim, Myung Geun Shin, Sae Gwang Park & Jin Han. BMB Reports -0001;0:. https://doi.org/10.5483/BMBRep.2024-0130

  • Open Access

    Optimization of Dye and Plasticizer Concentrations in Halochromic Sensor Films for Rapid pH Response Using Bird-Inspired Metaheuristic Algorithms

    by Daeuk Kim, Ronnie S. Concepcion, Joseph Rey H. Sta. Agueda, Jubert C. Marquez

    The pH level of a wound environment is a crucial biomarker for monitoring wound healing, particularly in chronic wounds, where alkalinity (pH > 7) is linked to bacterial colonization and infection. This study developed and optimized a halochromic sensor film composed of polyvinyl alcohol (PVA), polyethylene glycol (PEG), and bromothymol blue (BTB) to enable rapid and reliable pH-responsive color transitions. Feature selection using Principal Component Analysis (PCA) and the ReliefF algorithm identified Hue, Saturation, and a as key features influencing pH responsivity. Optimization of BTB (0.01–0.05%) and PEG (6–10%) concentrations was conducted using bird-inspired metaheuristic algorithms, including the Parrot Optimizer (PO), Pelican Optimization Algorithm (POA), and Secretary Bird Optimization Algorithm (SBOA). While final fitness values showed negligible variation (188.595647 for GP-PO, 188.595634 for GP-POA, and 188.595634 for GP-SBOA), GP-PO demonstrated superior convergence and stability, efficiently identifying the optimal formulation (0.02% BTB, 6% PEG). The optimized film achieved a complete color transition within 3–5 min, a 23.15% reduction compared to the non-optimized formulation. Statistical analysis revealed that BTB concentration significantly affected response time (p = 0.01), while PEG concentration had no significant effect (p > 0.05). These findings highlight the potential of halochromic films for real-time, non-invasive pH monitoring in chronic wounds.


  • Cereblon contributes to cardiac dysfunction by degrading Cav1.2α

    by Nammi Park, Jubert Marquez, Trong Kha Pham, Tae Hee Ko, Jae Boum Youm, Min Kim, Seung Hak Choi, Jiyoung Moon, Jessa Flores, Kyung Soo Ko, et al.

    Cereblon (CRBN) is a substrate receptor of the E3 ubiquitin ligase complex that was reported to target ion channel proteins. L-type voltage-dependent Ca2+ channel (LTCC) density and dysfunction is a critical player in heart failure with reduced ejection fraction (HFrEF). However, the underlying cellular mechanisms by which CRBN regulates LTCC subtype Cav1.2α during cardiac dysfunction remain unclear. Here, we explored the role of CRBN in HFrEF by investigating the direct regulatory role of CRBN in Cav1.2α activity and examining how it can serve as a target to address myocardial dysfunction. Cardiac tissues from HFrEF patients exhibited increased levels of CRBN compared with controls. In vivo and ex vivo studies demonstrated that whole-body CRBN knockout (CRBN−/−) and cardiac-specific knockout mice (Crbnfl/fl/Myh6Cre+) exhibited enhanced cardiac contractility with increased LTCC current (I CaL) compared with their respective controls, which was modulated by the direct interaction of CRBN with Cav1.2α. Mechanistically, the Lon domain of CRBN directly interacted with the N-terminal of Cav1.2α. Increasing CRBN levels enhanced the ubiquitination and proteasomal degradation of Cav1.2α and decreased I CaL. In contrast, genetic or pharmacological depletion of CRBN via TD-165, a novel PROTAC-based CRBN degrader, increased surface expression of Cav1.2α and enhanced I CaL. Low CRBN levels protected the heart against cardiomyopathy in vivo. Cereblon selectively degrades Cav1.2α, which in turn facilitates cardiac dysfunction. A targeted approach or an efficient method of reducing CRBN levels could serve as a promising strategy for HFrEF therapeutics. Patients with HFrEF exhibited increased CRBN expression that leads to Cav 1.2 degradation. CRBN directly binds and degrades Cav1.2α through ubiquitination. Cardiomyopathological model of CRBN KO mice improved cardiac contractility with increased Ca2+ transients and Cav1.2α current density.


  • Open Access

    Phosphorylation in Novel Mitochondrial Creatine Kinase Tyrosine Residues Render Cardioprotection against Hypoxia/Reoxygenation Injury

    by Nammi Park, Jubert Marquez, Maria Victoria Faith Garcia, Ippei Shimizu, Sung Ryul Lee, Hyoung Kyu Kim, Jin Han

    Park N, et al. J Lipid Atheroscler. 2021 May;10(2):223-239. https://doi.org/10.12997/jla.2021.10.2.223


  • HS-1793 protects C2C12 cells from oxidative stress via mitochondrial function regulation

    by Jubert Marquez, Nammi Park, Maria Victoria Faith Garcia, Hyoung Kyu Kim, Jin Han